SAN DIEGO, Jan. 23, 2018 -- The opioid crisis has become a national epidemic, and finding the right inpatient drug rehab in Georgia for some can mean the difference between life or death. A national substance abuse information provider The Recover has completed a complete guide to drug rehab centers in Georgia and what to expect when entering into treatment. The new page also shows the recent statistics of drug abuse in 2018, and laws pertaining to drug charges.
|
|||||
Georgia has such an opioid problem that the popular show on A&E “Intervention” focused on Cobb County and its part as one of the largest heroin drug rings in America. Communities within the affluent Atlanta suburbs known as “The Heroin Triangle” like Cobb has the state of Georgia ranked as one of the highest suffering from the opioid epidemic. Recent data from the department of health shows 55 of Georgia’s 159 counties had higher drug overdose rates than the U.S. average.
November of 2017 of last year the White House's Council of Economic Advisers estimated that the opioid crisis cost the country $504 billion. Nationally, healthcare workers are now experiencing more than 30,000 opioid-related deaths a year, 10 times as many hospital admissions, and a million emergency room visits.
Experts agree those looking for extended recovery success should enter into a long term drug rehab in Georgia. Short term treatment rarely works for long term recovery. The new Georgia drug information page explains the different options for patient’s including detox, inpatient, and outpatient care for drugs or alcohol. Treatment programs can range from 28 days all the way to 90 days, and aftercare programs that last for up to 12 months. In addition, on-going therapy which can include meetings or counseling can be a part of recovering addicts’ routine forever.
Author: Kevin Leonard
Organization: TheRecover.com
Address: 402 West Broadway, #400, San Diego, CA 92101
Phone: 888-510-3898
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/71764f73-5ec7-43da-b1cc-80d8a4502855


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Anta Sports Expands Global Footprint With Strategic Puma Stake
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



